Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Automated Inoculation System Provides Accurate Dosing of MIC Plates

By LabMedica International staff writers
Posted on 25 Jul 2011
An automated, inoculation delivery system provides faster, accurate dosing of minimum inhibitory concentration (MIC) plates for microbiology laboratories.

With a small-footprint and compact, user-friendly design, the Sensititre AIM automated inoculation delivery system is ideal for use directly on the benchtop or under a microbiology safety cabinet, providing flexible storage and accessibility and conserving valuable laboratory space. More...
It prevents missed wells and eliminates the need for repeat tests, improves laboratory workflow, and speeds results to clinicians.

The Sensititre AIM delivery system can be used with all Sensititre dried plates and quickly doses microtiter plates. The easy-to-use, icon-driven touch screen facilitates quick selection of dosing volumes and patterns for simple, intuitive operation.

TREK diagnostic systems' (Cleveland, OH, USA) Sensititre product line for susceptibility and identification testing enables labs to test US Food and Drug Administration (FDA; Silver Spring, MD, USA)-cleared antimicrobial drugs against a wide range of non-fastidious and fastidious bacteria and yeasts. This saves microbiology labs from having to use multiple off-line test procedures to obtain accurate susceptibility data.

The FDA cleared the TREK diagnostic systems-brand Sensititre AIM automated inoculation delivery system for in vitro diagnostics use in the United States. The AIM System has been used successfully in veterinary and pharmaceutical labs since its development. The AIM System is also CE-marked for sale outside the US.

Thermo Fisher Scientific Inc. (Waltham, MA, USA) has acquired TREK Diagnostic Systems, including blood culture, microorganism identification, and antibiotic susceptibility testing (AST) products, from Magellan Biosciences (Chelmsford, MA, USA). TREK Diagnostic Systems currently serves pharmaceutical and clinical laboratory markets and will be integrated into Thermo Fisher’s analytical technologies segment.

Related Links:

TREK diagnostic systems
US Food and Drug Administration
Thermo Fisher Scientific Inc.



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.